Hopper Jonathan Mark's Form 4 filing
Vericel Corp (VCEL) · filed May 21, 2024
- Accession no.
- 0001140361-24-027027
- Filed
- May 21, 2024
- Trade date
- May 20, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $499.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopper Jonathan MarkCIK 0001626325 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $10.95 | +$109,500 | 68,116 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −10,000 | $49.99 | −$499,900 | 58,116 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $0.00 | $0 | 22,604 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.